Benedict- non infectious mucosal diseases Flashcards

(24 cards)

1
Q

Describe the types of oral lichen planus

A
  • Keratotic: reticular, papular, annular, plaque-like
  • Erosive: irregular areas of ulceration covered by fibrin exudates/atrophic (epithelial thinning with erythmateous mucosa
  • Bullous: formation of bullae that rupture ulcerated and painful surface
  • desquamative gingivitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe how lichen planus occurs

A
  • body is challenged
  • basal epithelial cells express a different antigen
  • detected by apcs-> recruitment of T helper cells
  • t cytotoxic cells are stimulated and induce apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some important characteristics of lichen planus?

A
  • Bilateral
  • Symmetrical
  • Asymptomatic unless erosive/ulcerative
    buccal mucosa, tongue, gingiva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the name for lesions that appear to look like lichen planus?

A

lichenoid lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe diagnosis of lichen planus

A
  • classical signs
  • proximity to restoration
  • drug reactions
  • histology to rule out candida
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe behaviour of lichen planus

A
  • chronic with periods of exacerbation and remission
  • 2-3% malignant transformation especially erosive/ulcerative forms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe management of lichen planus

A
  • Asymptomatic: no treatment
  • Symptomatic: topical corticosteroid
  • Consider antifungal as needed
  • Regular review
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe mucous membrane pemphigoid

A
  • Autoimmune, vesiculobullous mucocutaneous disease with predilection for mucosal sites (subepithelial)
  • cicatricial: tendency to scar
  • ocular involvement: dryness, scarring affecting vision
    other bodily mucosal involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

who is more prone to mucous membrane pemphigoid

A

women, 50-80 yrs old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are symptoms of mucous membrane pemphigoid

A
  • easily traumatised palate, buccal mucosa, gingiva
  • bullae: rupture and cause scarring
  • positive nikolsky sign
  • lesions are chronic, painful, persistent
  • desquamative gingivitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is desquamative gingivitis and when is it seen?

A

bright red patches or confluent ulcers in the attached gingiva with discomfort
OLP and MMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the target (autoimmune of MMP)

A

hemidesmosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe behaviour of MMP

A
  • chronic (remission and relapse)
  • good prognosis but significant morbidity (steroid side effect, ocular scarring)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe management of MMP

A

Ophthamology consult
Oral lesions-topical steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe pemphigus

A
  • Autoimmune vesiculobullous mucocutaneous lesion
  • intra-epithelial blister formation
  • blisters rupture to cause a widespread ulceration
  • Can cause painful debilitation fluid loss and electrolyte imbalance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the oral clinical presentation of pemphigus

A
  • oral mucosal changes first sign 60%
  • Widespread superficial painful erosions and ulcerations distributed haphazardly
  • Positive nikolsky sign
  • easily traumatised areas
17
Q

Describe the bodily clinical presentation of pemphigus

A
  • Eventually all pts develop cutaneous lesion
  • flaccid cutaneous bullae quickly ruptures leaving erythematous denuded area
  • infrequently, ophthalmic involvement
18
Q

Describe behaviour of pemphigoid

A
  • chronic: rarely results in complete resolution
  • Corticosteroid reduce morbidity and mortality
  • Previously 60-70% died due to infection and fluid loss/electrolyte imbalance
  • today 5-10% mortality
19
Q

Describe management of pemphigoid

A
  • Initial high dose of systemic corticosteroid to control lesion, then lower dose
  • often combined with steroid-sparing agents (azathioprine)
  • Monitor circulating autoAB using indirect IF
20
Q

Describe erythema multiforme

A
  • Acute vesticulobullous mucotaneous disease
  • immune mediated, due to a hypersensitivity
  • Characterised by a wide range of clinical presentations
21
Q

When/who is more likely to have erythema multiforme?

A

Males 20s-30s (older females for toxic epidermal necrolysis)
- herpes (prev infection
- May have been taking medication

22
Q

Describe oral presentation of erythema multiforme

A
  • begins as erythemateous patches that undergo epithelial necrosis
  • Result in diffuse, large, shallow erosions and ulcerations with irregular border
  • Appear quickly and is painful
  • Hard palate and gingiva are spared (keratinised)
  • Haemorragic crusing at vermillion border-diagnostic
23
Q

Describe skin presentation of erythema multiforme

A
  • 1/2 of cases
  • bullseye target shaped lesions
  • evolve into bullae with necrotic centres
  • typically on extremities
24
Q

Describe management of erythema multiforme

A
  • mild forms subside in ~10 days
  • likelihood of recurrence
  • Mortality: EM major 10%, TEN 30%
  • systemic or local corticosteroid
  • Rehydration if dehydrated
  • prophylactic acyclovir against herpes